4-Phenyl-2-[6-(4-phenyl-4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-yl]-4,5-dihydro-1,3-oxazole | 342043-03-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-Phenyl-2-[6-(4-phenyl-4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-yl]-4,5-dihydro-1,3-oxazole
• CAS: 342043-03-2
• 化学式: C₂₃H₁₉N₃O₂
• 分子量: 369.4
• InChiKey: HLHBIMJNCKZZQO-UHFFFAOYSA-N

物化性质

• 沸点：
  600.4±55.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  56.1
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• Method for the synthesis of phospholipid ethers
  申请人：Pinchuk Anatoly

  公开号：US20080312459A1

  公开（公告）日：2008-12-18

  Disclosed are improved methods for the synthesis of phospholipid ether analogs and alkyl phosphocholine analogs. The methods allow greater versatility of the reactants used and greater ease in synthesizing alkyl chains of varying length while affording reaction temperatures at room temperature or below. The methods disclosed herein provide reactants and conditions using alkyl halides and organozinc reagents and do not utilize Gringard reactions thus, allowing greater ease of their separation and purity of products. The PLE compounds synthesized by the methods disclosed herein can also be used for synthesizing high specific activity phospholipid ether (PLE) analogs, for use in treatment and diagnosis of cancer.

  揭示了改进的合成磷脂醚类似物和烷基磷胆碱类似物的方法。这些方法允许使用更多种反应物，并更容易合成不同长度的烷基链，同时在室温或更低温度下进行反应。本文所披露的方法提供了使用烷基卤化物和有机锌试剂的反应物和条件，不使用格林纳德反应，从而使它们更容易分离并提高产品的纯度。通过本文披露的方法合成的PLE化合物也可用于合成高特异活性的磷脂醚（PLE）类似物，用于癌症的治疗和诊断。
• [EN] PYRANO[3,2-c][2]BENZOPYRAN-6(2H)-ONE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE PYRANO[3,2-C][2]BENZOPYRAN-6(2H)-ONE ET LEURS UTILISATIONS
  申请人：PROUS INST FOR BIOMEDICAL RES S A

  公开号：WO2013045495A1

  公开（公告）日：2013-04-04

  The present invention relates to new pyrano[3,2-c][2]benzopyran-6(2H)-one derivatives that act as SGLT2 inhibitors, which makes them promising candidates for the treatment of diabetes and other diseases and conditions mediated by SGLT2. These new drugs also exhibit platelet aggregation inhibitory activity which makes them promising candidates in the treatment and/or prevention of prothrombotic conditions. The invention also relates to the use of such pyrano[3,2-c][2]benzopyran-6(2W)-one derivatives in the treatment or prevention of the diabetes and other disorders and conditions mediated by SGLT2, as a single active ingredient or in combination with another antidiabetic agent or a drug for the treatment of hypertension, chronic heart failure or atherosclerosis, and pharmaceutical compositions comprising said new pyrano[3,2-c][2]benzopyran-6(2H)-one derivatives.

  本发明涉及新型的吡喃并[3,2-c][2]苯并吡喃-6(2H)-酮衍生物，它们作为SGLT2抑制剂发挥作用，使其成为治疗糖尿病及其他由SGLT2介导的疾病和病症的有前景的候选药物。这些新型药物还显示出抑制血小板聚集的活性，这使它们成为治疗和/或预防血栓形成状态的有前景的候选药物。本发明还涉及这类吡喃并[3,2-c][2]苯并吡喃-6(2H)-酮衍生物在治疗或预防糖尿病及其他由SGLT2介导的紊乱和病症中的应用，可以作为单一活性成分，或与另一种抗糖尿病药物或治疗高血压、慢性心力衰竭或动脉粥样硬化的药物联合使用，以及包含所述新型吡喃并[3,2-c][2]苯并吡喃-6(2H)-酮衍生物的药物组合物。
• Homogeneous asymmetric hydrogenation catalyst
  申请人：Shimizu Hideo

  公开号：US20090203927A1

  公开（公告）日：2009-08-13

  Provide that a useful catalyst for homogeneous hydrogenation, particularly a catalyst for homogeneous asymmetric hydrogenation for hydrogenation, particularly asymmetric hydrogenation, which is obtainable with comparative ease and is excellent in economically and workability, and a process for producing a hydrogenated compound of an unsaturated compound, particularly an optically active compound using said catalyst with a high yield and optical purity.

  提供一种用于均相氢化的有用催化剂，特别是用于均相不对称氢化的催化剂，特别是不对称氢化的催化剂，该催化剂易于获得，在经济性和可操作性方面表现出色，以及一种使用该催化剂产生不饱和化合物的氢化物的方法，特别是使用高产率和光学纯度的该催化剂产生手性活性化合物。
• Compound, Method for Producing the Same, and Method for Producing Oseltamivir Phosphate
  申请人：Microbial Chemistry Research Foundation

  公开号：US20140046087A1

  公开（公告）日：2014-02-13

  A compound represented by the following general formula (1), and a method for producing the compound represented by the general formula (1), the method comprising: reacting together a compound represented by the following general formula (2), a compound represented by the following general formula (3), and a compound represented by the following general formula (4): wherein R 1 represents any of a protective group of a carboxyl group, and a hydrogen atom, R 2 and R 3 each independently represent any of a protective group of an amino group, and a hydrogen atom, and R 4 represents any of a protective group of a carboxyl group, and a hydrogen atom.

  以下为通用公式（1）所代表的化合物，以及制备通用公式（1）所代表的化合物的方法，该方法包括：将以下通用公式（2）所代表的化合物、以下通用公式（3）所代表的化合物和以下通用公式（4）所代表的化合物反应在一起：其中，R1表示羧基的保护基中的任意一种，或氢原子；R2和R3各自独立地表示氨基的保护基中的任意一种，或氢原子；R4表示羧基的保护基中的任意一种，或氢原子。
• COMPOUND AND METHOD FOR PRODUCING SAME, AS WELL AS METHOD FOR PRODUCING OSELTAMIVIR PHOSPHATE
  申请人：Microbial Chemistry Research Foundation

  公开号：EP3235797A1

  公开（公告）日：2017-10-25

  A compound represented by the following general formula (6), a method for producing it, and its use in the preparation of oseltamivir phosphate.

  一种由以下通式（6）表示的化合物、其制备方法以及其在制备奥司他韦磷酸盐中的用途。